Your Opportunity to Present a Virtual Poster!
Taking place on conference day one and day two, the poster session will give you the chance to connect with your peers and share the latest and greatest advancements within the preclinical oncology world.
During this session, scientific posters will be presented with the latest preclinical data, utilizing both classical and next-generation models, highlighting a variety of breakthroughs from MoA studies to target validation to infiltration of the TME.
Whilst the turbulence of the past year is not yet over, this industry-dedicated poster session will bring the preclinical and translational community together to share and hear exciting data updates.
What Do I Need to Take Part?
- Ensure you’re registered to the conference
- Submit your poster abstract for review before Friday, July 3, 2021.
Submission Guidelines & Requirements
Deadline: Friday, July 3, 2021
The poster session is reserved exclusively for drug developers, academics, and clinicians and will give you the chance to showcase your research. Submissions must be 150-200 words max.
Please email us at email@example.com if you have any questions regarding the poster session.
*There is no additional charge but we ask that poster displays are not used for sales or marketing purposes. All poster abstracts are subject to approval by the conference organizers.